UNSPSC 51111869: Trilostane

This classification denotes a 3-hydroxysteroid dehydrogenase inhibitor and steroidal aromatase inhibitor and anti-adrenal with the molecular formula C20H27NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L0FPV48Q5R, chemically known as 5-alpha-androstane-2-alpha-carbonitrile, 4-alpha,5-epoxy-17-beta-hydroxy-3-oxo- but generally known as trilostane, which bears US NIH Compound Identifier 26163. European Medicines Agency schedules Trilostane in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11297MIG.

UNSPSC 51111869 Trilostane is a Commodity-tier code for the veterinary pharmaceutical trilostane, used primarily to treat Cushing's syndrome in dogs. The source provides no recent state and local contract opportunities under this code.

The absence of recent solicitations under this Commodity code suggests minimal or no active procurement activity by state and local governments for trilostane. State and local buyers typically source veterinary pharmaceuticals through existing supplier relationships, cooperative purchasing agreements, or standing contracts rather than through open competitive solicitations, which may explain the lack of visible opportunities in this category.